Biological Sequence Analysis Probabilistic Models of Proteins and Nucleic Acids
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
RDA COVID-19 Recommendations and Guidelines on Data Sharing
RDA COVID-19 Recommendations and Guidelines on Data Sharing DOI: 10.15497/RDA00052 Authors: RDA COVID-19 Working Group Published: 30th June 2020 Abstract: This is the final version of the Recommendations and Guidelines from the RDA COVID19 Working Group, and has been endorsed through the official RDA process. Keywords: RDA; Recommendations; COVID-19. Language: English License: CC0 1.0 Universal (CC0 1.0) Public Domain Dedication RDA webpage: https://www.rd-alliance.org/group/rda-covid19-rda-covid19-omics-rda-covid19- epidemiology-rda-covid19-clinical-rda-covid19-1 Related resources: - RDA COVID-19 Guidelines and Recommendations – preliminary version, https://doi.org/10.15497/RDA00046 - Data Sharing in Epidemiology, https://doi.org/10.15497/RDA00049 - RDA COVID-19 Zotero Library, https://doi.org/10.15497/RDA00051 Citation and Download: RDA COVID-19 Working Group. Recommendations and Guidelines on data sharing. Research Data Alliance. 2020. DOI: https://doi.org/10.15497/RDA00052 RDA COVID-19 Recommendations and Guidelines on Data Sharing RDA Recommendation (FINAL Release) Produced by: RDA COVID-19 Working Group, 2020 Document Metadata Identifier DOI: https://doi.org/10.15497/rda00052 Citation To cite this document please use: RDA COVID-19 Working Group. Recommendations and Guidelines on data sharing. Research Data Alliance. 2020. DOI: https://doi.org/10.15497/rda00052 Title RDA COVID-19; Recommendations and Guidelines on Data Sharing, Final release 30 June 2020 Description This is the final version of the Recommendations and Guidelines -
Gene Prediction: the End of the Beginning Comment Colin Semple
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central http://genomebiology.com/2000/1/2/reports/4012.1 Meeting report Gene prediction: the end of the beginning comment Colin Semple Address: Department of Medical Sciences, Molecular Medicine Centre, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. E-mail: [email protected] Published: 28 July 2000 reviews Genome Biology 2000, 1(2):reports4012.1–4012.3 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2000/1/2/reports/4012 © GenomeBiology.com (Print ISSN 1465-6906; Online ISSN 1465-6914) Reducing genomes to genes reports A report from the conference entitled Genome Based Gene All ab initio gene prediction programs have to balance sensi- Structure Determination, Hinxton, UK, 1-2 June, 2000, tivity against accuracy. It is often only possible to detect all organised by the European Bioinformatics Institute (EBI). the real exons present in a sequence at the expense of detect- ing many false ones. Alternatively, one may accept only pre- dictions scoring above a more stringent threshold but lose The draft sequence of the human genome will become avail- those real exons that have lower scores. The trick is to try and able later this year. For some time now it has been accepted increase accuracy without any large loss of sensitivity; this deposited research that this will mark a beginning rather than an end. A vast can be done by comparing the prediction with additional, amount of work will remain to be done, from detailing independent evidence. -
The EMBL-European Bioinformatics Institute the Hub for Bioinformatics in Europe
The EMBL-European Bioinformatics Institute The hub for bioinformatics in Europe Blaise T.F. Alako, PhD [email protected] www.ebi.ac.uk What is EMBL-EBI? • Part of the European Molecular Biology Laboratory • International, non-profit research institute • Europe’s hub for biological data, services and research The European Molecular Biology Laboratory Heidelberg Hamburg Hinxton, Cambridge Basic research Structural biology Bioinformatics Administration Grenoble Monterotondo, Rome EMBO EMBL staff: 1500 people Structural biology Mouse biology >60 nationalities EMBL member states Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom Associate member state: Australia Who we are ~500 members of staff ~400 work in services & support >53 nationalities ~120 focus on basic research EMBL-EBI’s mission • Provide freely available data and bioinformatics services to all facets of the scientific community in ways that promote scientific progress • Contribute to the advancement of biology through basic investigator-driven research in bioinformatics • Provide advanced bioinformatics training to scientists at all levels, from PhD students to independent investigators • Help disseminate cutting-edge technologies to industry • Coordinate biological data provision throughout Europe Services Data and tools for molecular life science www.ebi.ac.uk/services Browse our services 9 What services do we provide? Labs around the -
Functional Effects Detailed Research Plan
GeCIP Detailed Research Plan Form Background The Genomics England Clinical Interpretation Partnership (GeCIP) brings together researchers, clinicians and trainees from both academia and the NHS to analyse, refine and make new discoveries from the data from the 100,000 Genomes Project. The aims of the partnerships are: 1. To optimise: • clinical data and sample collection • clinical reporting • data validation and interpretation. 2. To improve understanding of the implications of genomic findings and improve the accuracy and reliability of information fed back to patients. To add to knowledge of the genetic basis of disease. 3. To provide a sustainable thriving training environment. The initial wave of GeCIP domains was announced in June 2015 following a first round of applications in January 2015. On the 18th June 2015 we invited the inaugurated GeCIP domains to develop more detailed research plans working closely with Genomics England. These will be used to ensure that the plans are complimentary and add real value across the GeCIP portfolio and address the aims and objectives of the 100,000 Genomes Project. They will be shared with the MRC, Wellcome Trust, NIHR and Cancer Research UK as existing members of the GeCIP Board to give advance warning and manage funding requests to maximise the funds available to each domain. However, formal applications will then be required to be submitted to individual funders. They will allow Genomics England to plan shared core analyses and the required research and computing infrastructure to support the proposed research. They will also form the basis of assessment by the Project’s Access Review Committee, to permit access to data. -
Curriculum Vitae – Prof. Anders Krogh Personal Information
Curriculum Vitae – Prof. Anders Krogh Personal Information Date of Birth: May 2nd, 1959 Private Address: Borgmester Jensens Alle 22, st th, 2100 København Ø, Denmark Contact information: Dept. of Biology, Univ. of Copenhagen, Ole Maaloes Vej 5, 2200 Copenhagen, Denmark. +45 3532 1329, [email protected] Web: https://scholar.google.com/citations?user=-vGMjmwAAAAJ Education Sept 1991 Ph.D. (Physics), Niels Bohr Institute, Univ. of Copenhagen, Denmark June 1987 Cand. Scient. [M. Sc.] (Physics and mathematics), NBI, Univ. of Copenhagen Professional / Work Experience (since 2000) 2018 – Professor of Bionformatics, Dept of Computer Science (50%) and Dept of Biology (50%), Univ. of Copenhagen 2002 – 2018 Professor of Bionformatics, Dept of Biology, Univ. of Copenhagen 2009 – 2018 Head of Section for Computational and RNA Biology, Dept. of Biology, Univ. of Copenhagen 2000–2002 Associate Prof., Technical Univ. of Denmark (DTU), Copenhagen Prices and Awards 2017 – Fellow of the International Society for Computational Biology https://www.iscb.org/iscb- fellows-program 2008 – Fellow, Royal Danish Academy of Sciences and Letters Public Activities & Appointments (since 2009) 2014 – Board member, Elixir, European Infrastructure for Life Science. 2014 – Steering committee member, Danish Elixir Node. 2012 – 2016 Board member, Bioinformatics Infrastructure for Life Sciences (BILS), Swedish Research Council 2011 – 2016 Director, Centre for Computational and Applied Transcriptomics (COAT) 2009 – Associate editor, BMC Bioinformatics Publications § Google Scholar: https://scholar.google.com/citations?user=-vGMjmwAAAAJ § ORCID: 0000-0002-5147-6282. ResearcherID: M-1541-2014 § Co-author of 130 peer-reviewed papers and 2 monographs § 63,000 citations and h-index of 74 (Google Scholar, June 2019) § H-index of 54 in Web of science (June 2019) § Publications in high-impact journals: Nature (5), Science (1), Cell (1), Nature Genetics (2), Nature Biotechnology (2), Nature Communications (4), Cell (1, to appear), Genome Res. -
UC Irvine UC Irvine Previously Published Works
UC Irvine UC Irvine Previously Published Works Title The capacity of feedforward neural networks. Permalink https://escholarship.org/uc/item/29h5t0hf Authors Baldi, Pierre Vershynin, Roman Publication Date 2019-08-01 DOI 10.1016/j.neunet.2019.04.009 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California THE CAPACITY OF FEEDFORWARD NEURAL NETWORKS PIERRE BALDI AND ROMAN VERSHYNIN Abstract. A long standing open problem in the theory of neural networks is the devel- opment of quantitative methods to estimate and compare the capabilities of different ar- chitectures. Here we define the capacity of an architecture by the binary logarithm of the number of functions it can compute, as the synaptic weights are varied. The capacity provides an upperbound on the number of bits that can be extracted from the training data and stored in the architecture during learning. We study the capacity of layered, fully-connected, architectures of linear threshold neurons with L layers of size n1, n2,...,nL and show that in essence the capacity is given by a cubic polynomial in the layer sizes: L−1 C(n1,...,nL) = Pk=1 min(n1,...,nk)nknk+1, where layers that are smaller than all pre- vious layers act as bottlenecks. In proving the main result, we also develop new techniques (multiplexing, enrichment, and stacking) as well as new bounds on the capacity of finite sets. We use the main result to identify architectures with maximal or minimal capacity under a number of natural constraints. -
Contributions to Biostatistics: Categorical Data Analysis, Data Modeling and Statistical Inference Mathieu Emily
Contributions to biostatistics: categorical data analysis, data modeling and statistical inference Mathieu Emily To cite this version: Mathieu Emily. Contributions to biostatistics: categorical data analysis, data modeling and statistical inference. Mathematics [math]. Université de Rennes 1, 2016. tel-01439264 HAL Id: tel-01439264 https://hal.archives-ouvertes.fr/tel-01439264 Submitted on 18 Jan 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. HABILITATION À DIRIGER DES RECHERCHES Université de Rennes 1 Contributions to biostatistics: categorical data analysis, data modeling and statistical inference Mathieu Emily November 15th, 2016 Jury: Christophe Ambroise Professeur, Université d’Evry Val d’Essonne, France Rapporteur Gérard Biau Professeur, Université Pierre et Marie Curie, France Président David Causeur Professeur, Agrocampus Ouest, France Examinateur Heather Cordell Professor, University of Newcastle upon Tyne, United Kingdom Rapporteur Jean-Michel Marin Professeur, Université de Montpellier, France Rapporteur Valérie Monbet Professeur, Université de Rennes 1, France Examinateur Korbinian Strimmer Professor, Imperial College London, United Kingdom Examinateur Jean-Philippe Vert Directeur de recherche, Mines ParisTech, France Examinateur Pour M.H.A.M. Remerciements En tout premier lieu je tiens à adresser mes remerciements à l’ensemble des membres du jury qui m’ont fait l’honneur d’évaluer mes travaux. -
Predicting Transmembrane Topology and Signal Peptides with Hidden Markov Models
i i “thesis” — 2006/3/6 — 10:55 — page i — #1 i i From the Center for Genomics and Bioinformatics, Karolinska Institutet, Stockholm, Sweden Predicting transmembrane topology and signal peptides with hidden Markov models Lukas Käll Stockholm, 2006 i i i i i i “thesis” — 2006/3/6 — 10:55 — page ii — #2 i i ©Lukas Käll, 2006 Except previously published papers which were reproduced with permission from the publisher. Paper I: ©2002 Federation of European Biochemical Societies Paper II: ©2004 Elsevier Ltd. Paper III: ©2005 Federation of European Biochemical Societies Paper IV: ©2005 Lukas Käll, Anders Krogh and Erik Sonnhammer Paper V: ©2006 ¿e Protein Society Published and printed by Larserics Digital Print, Sundbyberg ISBN 91-7140-719-7 i i i i i i “thesis” — 2006/3/6 — 10:55 — page iii — #3 i i Abstract Transmembrane proteins make up a large and important class of proteins. About 20% of all genes encode transmembrane proteins. ¿ey control both substances and information going in and out of a cell. Yet basic knowledge about membrane insertion and folding is sparse, and our ability to identify, over-express, purify, and crystallize transmembrane proteins lags far behind the eld of water-soluble proteins. It is dicult to determine the three dimensional structures of transmembrane proteins. ¿ere- fore, researchers normally attempt to determine their topology, i.e. which parts of the protein are buried in the membrane, and on what side of the membrane are the other parts located. Proteins aimed for export have an N-terminal sequence known as a signal peptide that is in- serted into the membrane and cleaved o. -
Download Final Programme
Session Overview Saturday 17 September 2011 11:15 - 13:15 Arrival and Registration ATC Main Entrance 13:15 - 13:30 Welcome and Opening Remarks Klaus Tschira Auditorium 13:30 - 18:00 Session 1: Somatic Genetics I Chaired by David Tuveson and Ewan Birney Klaus Tschira Auditorium 18:00 - 19:00 Keynote Lecture: Lynda Chin Klaus Tschira Auditorium 19:00 - 20:30 Dinner ATC Canteen Sunday 18 September 2011 09:00 - 12:30 Session 2: Somatic Genetics II / Epigenetics Chaired by James R. Downing Klaus Tschira Auditorium 12:30 - 14:30 Poster Session I and Lunch ATC Foyer and Helix A 14:30 - 18:30 Session 3: Mouse Genetics Chaired by Lynda Chin Klaus Tschira Auditorium 18:30 - 23:00 Gala Dinner and Live Music ATC Canteen and ATC Rooftop Lounge Page 1 EMBO|EMBL Symposium: Cancer Genomics Monday 19 September 2011 09:00 - 13:00 Session 4: Computational Chaired by Peter Lichter Klaus Tschira Auditorium 13:00 - 15:00 Poster Session II and Lunch ATC Foyer and Helix A 15:00 - 16:00 Session 5: Somatic Genetics III Chaired by Andy Futreal Klaus Tschira Auditorium 16:00 - 17:00 Keynote Lecture: Michael Stratton Klaus Tschira Auditorium 17:00 - 17:15 Closing Remarks and Poster Prize Klaus Tschira Auditorium Page 2 Programme Saturday 17 September 2011 11:15 - 13:15 Arrival and Registration ATC Main Entrance 13:15 - 13:30 Welcome and Opening Remarks Klaus Tschira Auditorium 13:30 - 18:00 Session 1: Somatic Genetics I Chaired by David Tuveson and Ewan Birney Klaus Tschira Auditorium 13:30 - 14:00 Somatic genomic alterations in chronic lymphocytic 1 leukemia Elias -
Sequence Analysis Instructions
Sequence Analysis Instructions In order to predict your drug metabolizing phenotype from your CYP2D6 gene sequence, you must determine: 1) The assembled sequence from your two opposing sequencing reactions 2) If your PCR product even represents the human CYP2D6 gene, 3) The location of your sequence within the CYP2D6 gene, 4) Whether differences between your alleles and CYP2D6*1 sequence represents sequencing errors or polymorphisms in your sequence, and 5) The effect(s) of any polymorphisms on CYP2D6 protein sequence. As you analyze your gene sequence, copy and paste your analyses and results into a text file for your final lab report. If some factor, like the quality of your sequence, prevents you from carrying out the complete analysis, your grade will not be penalized—just complete as many of the steps below as possible, and include an explanation of why you could not complete the analysis in your final report. Font appearing in bold green italics describes questions to answer and items to include in your final report. Part 1: Assembling your CYP2D6 sequence from both directions The sequencing reaction only produces 700-800 bases of good sequence. To get most of the sequence of the 1.2 Kbp PCR product, sequencing reactions were performed from both directions on the PCR product. These need to be assembled into one sequence using the overlap of the two sequences. In order to assure that it is going in the forward direction, it is best to derive the reverse complement sequence from the reverse sequencing file. Take the text file and paste it into a program like http://www.bioinformatics.org/sms/rev_comp.html. -
Downloaded Were Considered to Be True Positive While Those from the from UCSC Databases on 14Th September 2011 [70,71]
Basu et al. BMC Bioinformatics 2013, 14(Suppl 7):S14 http://www.biomedcentral.com/1471-2105/14/S7/S14 RESEARCH Open Access Examples of sequence conservation analyses capture a subset of mouse long non-coding RNAs sharing homology with fish conserved genomic elements Swaraj Basu1, Ferenc Müller2, Remo Sanges1* From Ninth Annual Meeting of the Italian Society of Bioinformatics (BITS) Catania, Sicily. 2-4 May 2012 Abstract Background: Long non-coding RNAs (lncRNA) are a major class of non-coding RNAs. They are involved in diverse intra-cellular mechanisms like molecular scaffolding, splicing and DNA methylation. Through these mechanisms they are reported to play a role in cellular differentiation and development. They show an enriched expression in the brain where they are implicated in maintaining cellular identity, homeostasis, stress responses and plasticity. Low sequence conservation and lack of functional annotations make it difficult to identify homologs of mammalian lncRNAs in other vertebrates. A computational evaluation of the lncRNAs through systematic conservation analyses of both sequences as well as their genomic architecture is required. Results: Our results show that a subset of mouse candidate lncRNAs could be distinguished from random sequences based on their alignment with zebrafish phastCons elements. Using ROC analyses we were able to define a measure to select significantly conserved lncRNAs. Indeed, starting from ~2,800 mouse lncRNAs we could predict that between 4 and 11% present conserved sequence fragments in fish genomes. Gene ontology (GO) enrichment analyses of protein coding genes, proximal to the region of conservation, in both organisms highlighted similar GO classes like regulation of transcription and central nervous system development. -
Agenda: Gene Prediction by Cross-Species Sequence Comparison Leila Taher1, Oliver Rinner2,3, Saurabh Garg1, Alexander Sczyrba4 and Burkhard Morgenstern5,*
Nucleic Acids Research, 2004, Vol. 32, Web Server issue W305–W308 DOI: 10.1093/nar/gkh386 AGenDA: gene prediction by cross-species sequence comparison Leila Taher1, Oliver Rinner2,3, Saurabh Garg1, Alexander Sczyrba4 and Burkhard Morgenstern5,* 1International Graduate School for Bioinformatics and Genome Research, University of Bielefeld, Postfach 10 01 31, 33501 Bielefeld, Germany, 2GSF Research Center, MIPS/Institute of Bioinformatics, Ingolsta¨dter Landstrasse 1, 85764 Neuherberg, Germany, 3Brain Research Institute, ETH Zuurich,€ Winterthurerstrasse 190, CH-8057 Zuurich,€ Switzerland, 4Faculty of Technology, Research Group in Practical Computer Science, University of Bielefeld, Postfach 10 01 31, 33501 Bielefeld, Germany and 5Institute of Microbiology and Genetics, University of Go¨ttingen, Goldschmidtstrasse 1, 37077 Go¨ttingen, Germany Received March 5, 2004; Revised and Accepted March 24, 2004 ABSTRACT Thus, with the huge amount of data produced by sequencing projects, the development of high-quality gene-prediction Automatic gene prediction is one of the major tools has become a priority in bioinformatics. For eukaryotic challenges in computational sequence analysis. organisms, gene prediction is particularly challenging, since Traditional approaches to gene finding rely on statis- protein-coding exons are usually separated by introns of vari- tical models derived from previously known genes. By able length. Most traditional methods for gene prediction are contrast, a new class of comparative methods relies intrinsic methods; they use hidden Markov models (HMMs) or on comparing genomic sequences from evolutionary other stochastic approaches describing the statistical composi- related organisms to each other. These methods are tion of introns, exons, etc. Such models are trained with already based on the concept of phylogenetic footprinting: known genes from the same or a closely related species; the they exploit the fact that functionally important most popular of these tools is GenScan (1).